Matches in Wikidata for { <http://www.wikidata.org/entity/Q94403501> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q94403501 description "article scientifique publié en 2017" @default.
- Q94403501 description "wetenschappelijk artikel" @default.
- Q94403501 description "наукова стаття" @default.
- Q94403501 name "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 name "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 type Item @default.
- Q94403501 label "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 label "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 prefLabel "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 prefLabel "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 P1433 Q94403501-D8643EB0-459B-43C9-905A-E035E24E8A29 @default.
- Q94403501 P1476 Q94403501-B61F8F1C-8B5F-486F-ADFE-7E604D4CAC86 @default.
- Q94403501 P2093 Q94403501-1D572FD1-71EF-49B3-9ACA-3D2C4F3A14FC @default.
- Q94403501 P2093 Q94403501-1DC0B40F-D16A-459A-9E24-D48492D4CE21 @default.
- Q94403501 P2093 Q94403501-27434DB3-6861-42EF-AD1A-041F32F361E8 @default.
- Q94403501 P2093 Q94403501-38B7D92B-2560-4A39-A11F-DCA7474F5483 @default.
- Q94403501 P2093 Q94403501-61F12E41-A281-4BF3-AD26-EAD675539600 @default.
- Q94403501 P2093 Q94403501-61FA6C16-AED9-4B9A-9692-DDE9C4B432C1 @default.
- Q94403501 P2093 Q94403501-67FB6E2C-176E-4A7E-8BE2-B7D1F90FF95F @default.
- Q94403501 P2093 Q94403501-680644A9-E636-4731-9938-70472E759C4E @default.
- Q94403501 P2093 Q94403501-6EC6E3B1-670A-47B9-9A78-5B5440ECC0C3 @default.
- Q94403501 P2093 Q94403501-7804E298-8647-433F-A09E-FEB7BADEA5A0 @default.
- Q94403501 P2093 Q94403501-B978EBC8-AF49-48B1-AFB5-600BD8255F22 @default.
- Q94403501 P2093 Q94403501-C1A69516-C877-4463-9A6C-090663FB31BC @default.
- Q94403501 P2093 Q94403501-FCF1421D-6D04-471F-9437-D1C2B1DA8789 @default.
- Q94403501 P304 Q94403501-730DE555-B988-4F19-B6FF-F05343CE013B @default.
- Q94403501 P31 Q94403501-EF36DB0A-B398-4723-99DA-D90BA37AB42C @default.
- Q94403501 P356 Q94403501-D5D7A349-852E-4355-81A7-D63CC88D0D8C @default.
- Q94403501 P433 Q94403501-50A641E2-C368-4FB0-9C62-3AFBE8B32F18 @default.
- Q94403501 P478 Q94403501-CF9015BA-4014-497A-A1C1-6F15F6FAC0FE @default.
- Q94403501 P50 Q94403501-73a5d56f-440e-401e-d418-17a02affce9b @default.
- Q94403501 P577 Q94403501-00412A63-A259-4E2D-BC9C-40BD992675FB @default.
- Q94403501 P921 Q94403501-13E8443E-FDA7-4572-AAB8-A10D01E017CF @default.
- Q94403501 P921 Q94403501-2E36D024-CC30-4521-A468-327E6924299E @default.
- Q94403501 P921 Q94403501-AFFDA23C-A84B-4C9A-A51D-EB4F45619C5D @default.
- Q94403501 P921 Q94403501-C7BC276F-79EA-4C85-B596-40452FD3D6C9 @default.
- Q94403501 P932 Q94403501-8A9CC64E-5879-4178-86AD-91BCD5FA1FD7 @default.
- Q94403501 P356 NOX168.868 @default.
- Q94403501 P1433 Q15724471 @default.
- Q94403501 P1476 "RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94403501 P2093 "Bruce Korf" @default.
- Q94403501 P2093 "Coretta Thomas" @default.
- Q94403501 P2093 "James Tonsgard" @default.
- Q94403501 P2093 "Jashri Blakeley" @default.
- Q94403501 P2093 "Jeffrey Allen" @default.
- Q94403501 P2093 "Jian Campian" @default.
- Q94403501 P2093 "Matthias Karjannis" @default.
- Q94403501 P2093 "Michael Fisher" @default.
- Q94403501 P2093 "Nicole Ullrich" @default.
- Q94403501 P2093 "Roger Packer" @default.
- Q94403501 P2093 "Scott Plotkin" @default.
- Q94403501 P2093 "Tena Rosser" @default.
- Q94403501 P2093 "Wade Clapp" @default.
- Q94403501 P304 "vi215-vi215" @default.
- Q94403501 P31 Q13442814 @default.
- Q94403501 P356 "10.1093/NEUONC/NOX168.868" @default.
- Q94403501 P433 "Suppl 6" @default.
- Q94403501 P478 "19" @default.
- Q94403501 P50 Q89543066 @default.
- Q94403501 P577 "2017-11-06T00:00:00Z" @default.
- Q94403501 P921 Q1935832 @default.
- Q94403501 P921 Q413299 @default.
- Q94403501 P921 Q42824440 @default.
- Q94403501 P921 Q6934595 @default.
- Q94403501 P932 "5691935" @default.